To evaluate the IOP-lowering efficacy of bimatoprost 0.03% in patients found to be low-responders to latanoprost therapy.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Masking
NONE
Dr. Noecker
Pittsburgh, Pennsylvania, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.